跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,004 条关于
“MAESTRO-NASH”
全部
2,004
临床试验
1,485
药物
36
机构
24
资讯
459
去年
Madrigal Pharmaceuticals Initiates FDA Submission for NASH Treatment Resmetirom
2年前
Madrigal's Resmetirom Nears Full Approval for NASH Cirrhosis Treatment Following Phase 3 Enrollment Completion
去年
Rezdiffra Demonstrates Improved Quality of Life in NASH Patients with Fibrosis
去年
Resmetirom Shows Promise in Treating MASLD/MASH: A Comprehensive Review of Clinical Trials
去年
Madrigal Pharmaceuticals Reports Strong Rezdiffra Launch and Provides Corporate Updates
2年前
FDA Approves Rezdiffra (Resmetirom) as First Treatment for NASH with Liver Fibrosis
去年
Madrigal Pharmaceuticals Reports Strong Rezdiffra Launch and Clinical Progress in NASH/MASH
去年
FDA Approves Rezdiffra (resmetirom) for NASH with Liver Fibrosis
去年
Madrigal Pharmaceuticals Reports Strong Rezdiffra Launch and Clinical Progress in NASH/MASH
去年
Real-World Data Show Resmetirom Mirrors Clinical Trial Success in MASH Patients
第 1 页,共 46 页
上一页
下一页